华东医药 (000963)

HUADONG MEDICINE CO.,LTD

ASZ

Tags

300ESG Index300 Non-Cyclical IndexAI HealthcareMSCI Component StocksCSI 200 IndexArtificial Intelligence (AI)Generic DrugsInsurance Heavy PositionsImmunotherapyCold Chain LogisticsWeight Loss DrugsAnalyst Recommended StocksInnovative DrugsChemical PharmaceuticalsNorthbound Heavy PositionsMedical Aesthetics ConceptPharmaceuticals and HealthcareFace Mask ProtectionSynthetic BiologyPet EconomyEmerging Markets IndexPrivate Enterprises 100 IndexCSI 300 IndexConsumption 100 IndexSocial Security Fund Heavy PositionsHigh-Performing StocksHepatitis ConceptMargin Trading and Securities LendingIndustry LeadersChina Securities Finance and Central Huijin HoldingsYangtze River DeltaNon-Cyclical StocksHigh Accounts ReceivableShenzhen Main Board 50 IndexSZSE 100 IndexSZSE 300 IndexSZSE Innovation IndexSZSE Governance Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 175402.10
  • Circulating A-Shares(W): 175337.54
  • Earnings Per Share(RMB): 1.5682
  • Net Assets Per Share(RMB): 13.7586
  • Operating Revenue(W RMB): 3266414.31
  • Total Profit(W RMB): 326262.16
  • Net Profit Attributable to Parent(W RMB): 274791.60
  • Net Profit Growth Rate(%): 7.24
  • Weighted Return on Equity(%): 11.3900
  • Operating Cash Flow Per Share(RMB): 1.4890
  • Undistributed Profit Per Share(RMB): 10.5891
  • Capital Reserve Per Share(RMB): 1.3784

2. Main Business

The main business covers:

  • Pharmaceutical Industry
  • Pharmaceutical Commerce
  • Medical Aesthetics
  • Industrial Microbiology

3. Company Basic Information

  • Company Name: Huadong Medicine Co., Ltd.
  • Listing Date: 2000-01-27
  • Industry: Medicine & Healthcare - Chemical Pharmaceuticals
  • Address: 858 Moganshan Road, Gongshu District, Hangzhou City, Zhejiang Province
  • Website: www.eastchinapharm.com
  • Company Profile: The predecessor of the company, Hangzhou Pharmaceutical Station Co., Ltd., was established in March 1993 by way of private placement, with Hangzhou Pharmaceutical Purchasing and Supply Station as the main sponsor, jointly initiated by Hangzhou Minsheng Pharmaceutical Factory and Zhejiang Xinchang Pharmaceutical Co., Ltd. Hangzhou Pharmaceutical Purchasing and Supply Station was established in 1958 as a state-owned enterprise under the Hangzhou Pharmaceutical Administration Bureau. It was the largest pharmaceutical wholesale enterprise in Zhejiang Province, mainly engaged in six major categories of pharmaceutical products: drugs, Chinese medicinal materials, Chinese patent medicines, medical devices, chemical reagents, and glass instruments. It was promoted to a national second-class enterprise in 1990 and was a provincial and municipal credit excellent enterprise. In 1995, Hangzhou Huadong Pharmaceutical (Group) Company and Hangzhou Pharmaceutical Station Co., Ltd. carried out a joint reorganization. In October 1996, the Hangzhou State-owned Assets Bureau approved with document Hang Guozi [96] No. 183, authorizing Hangzhou Huadong Pharmaceutical (Group) Company to hold all the state shares of Hangzhou Pharmaceutical Station Co., Ltd. In November 1996, Hangzhou Pharmaceutical Station Co., Ltd. carried out a rights issue and changed its name after cleaning up and standardizing its original share capital structure. On January 17, 1997, the company completed the industrial and commercial change registration and was renamed Hangzhou Huadong Pharmaceutical Co., Ltd., with the total share capital increased to 140 million shares. Since then, the company has transformed from a purely commercial enterprise into a pharmaceutical production enterprise that integrates pharmaceutical product production and sales networks, closely combining industry and commerce.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 China Yuanda Group Co., Ltd. General Legal Person 73093.82 41.72
2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. General Legal Person 28800.00 16.44
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 5200.36 2.97
4 China Securities Finance Corporation Ltd. Special Legal Person 2218.68 1.27
5 China Europe Healthcare Hybrid Securities Investment Fund Class A Fund 2011.52 1.15
6 New China Life Insurance Co., Ltd. - Dividend - Individual Dividend - 018L-FH002 Shen Insurance 1979.20 1.13
7 National Social Security Fund 112 Portfolio Social Security Fund 1698.97 0.97
8 New China Life Insurance Co., Ltd. - Traditional - Ordinary Insurance Product - 018L-CT001 Shen Insurance 1559.71 0.89
9 Huatai-PineBridge CSI 300 ETF Fund 1488.22 0.85
10 E Fund CSI 300 Healthcare ETF Fund 1098.64 0.63

5. Concept Sectors

  • Immunotherapy
  • Artificial Intelligence
  • Generic Drugs
  • Mask Protection
  • Medical Aesthetics Concept
  • Cold Chain Logistics
  • Hepatitis Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology
  • Pet Economy
  • AI Healthcare
  • Margin Trading
  • Insurance Heavy Holdings
  • Blue Chip Stocks
  • Social Security Fund Heavy Holdings
  • Industry Leader
  • China Securities Finance & Central Huijin
  • MSCI Constituent
  • Northbound Heavy Holdings
  • Non-Cyclical Stocks
  • High Accounts Receivable
  • SZSE 100
  • SZSE 300
  • SZSE Governance
  • Consumption 100
  • Private Enterprise 100
  • CSI 300
  • CSI 200
  • 300 Non-Cyclical
  • SZSE Innovation
  • 300 ESG
  • Emerging Composite Index
  • Yangtze River Delta
  • SZSE Main Board 50
  • Analyst Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information